Frontlight ResearchEarly access
Head and neck cancer trials in Moldova
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- Where
- Chisinau
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Hummingbird Bioscience
See details and how to joinNCT05910827